A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Blackrock ETF Tr Future Health stock. As of the latest transaction made, Citadel Advisors LLC holds 13,608 shares of BMED stock, worth $340,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,608
Previous 33,618 59.52%
Holding current value
$340,608
Previous $823,000 56.5%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$24.15 - $26.42 $483,241 - $528,664
-20,010 Reduced 59.52%
13,608 $358,000
Q4 2023

Feb 14, 2024

BUY
$20.59 - $24.62 $120,163 - $143,682
5,836 Added 21.01%
33,618 $823,000
Q3 2023

Nov 14, 2023

BUY
$22.45 - $24.96 $102,192 - $113,617
4,552 Added 19.6%
27,782 $623,000
Q2 2023

Aug 14, 2023

BUY
$23.42 - $24.84 $63,889 - $67,763
2,728 Added 13.31%
23,230 $575,000
Q1 2023

May 15, 2023

BUY
$0.0 - $24.47 $0 - $109,552
4,477 Added 27.94%
20,502 $480,000
Q4 2022

Feb 14, 2023

BUY
$21.84 - $24.06 $40,294 - $44,390
1,845 Added 13.01%
16,025 $371,000
Q3 2022

Nov 14, 2022

SELL
$20.74 - $24.02 $595,943 - $690,190
-28,734 Reduced 66.96%
14,180 $297,000

Others Institutions Holding BMED

About BLACKROCK ETF TR FUTURE HEALTH


  • Ticker BMED
  • Sector ETFs
  • Industry ETFs
More about BMED
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.